Price T Rowe Associates Inc Exact Sciences Corp Transaction History

Price T Rowe Associates Inc

$816 Billion
Q1 2024

A detailed history of Price T Rowe Associates Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,345,238 shares of EXAS stock, worth $56.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,345,238

Previous 1,444,648 6.88%

Holding current value

$56.8 Million

Previous $107 Million 13.07%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$56.27 - $73.77 $5.59 Million - $7.33 Million	-99,410 Reduced 6.88%	1,345,238 $92.9 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $14.1 Million - $18.1 Million	-238,686 Reduced 14.18%	1,444,648 $107 Million
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $32.9 Million - $49.4 Million	-498,552 Reduced 22.85%	1,683,334 $115 Million
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $25.2 Million - $38.2 Million	402,314 Added 22.61%	2,181,886 $205 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $152 Million - $227 Million	-3,212,795 Reduced 64.35%	1,779,572 $121 Million

Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $24.9 Million - $43.7 Million	-821,810 Reduced 14.13%	4,992,367 $247 Million
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $307 Million - $474 Million	-9,608,207 Reduced 62.3%	5,814,177 $189 Million
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $134 Million - $286 Million	-3,757,848 Reduced 19.59%	15,422,384 $607 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $310 Million - $445 Million	5,392,099 Added 39.11%	19,180,232 $1.34 Billion
Q4 2021 Feb 14, 2022	SELL	$72.5 - $100.68 $342 Million - $475 Million	-4,716,911 Reduced 25.49%	13,788,133 $1.07 Billion
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $116 Million - $159 Million	-1,284,299 Reduced 6.49%	18,505,044 $1.77 Billion
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $140 Million - $208 Million	1,495,404 Added 8.17%	19,789,343 $2.46 Billion
Q1 2021 May 17, 2021	BUY	$116.57 - $155.01 $203 Million - $271 Million	1,745,691 Added 10.55%	18,293,939 $2.41 Billion
Q4 2020 Feb 16, 2021	BUY	$99.61 - $142.12 $1.65 Billion - $2.35 Billion	16,548,248 New	16,548,248 $2.19 Billion

Others Institutions Holding EXAS

# of Institutions

699

Shares Held

160M

Call Options Held

5.84M

Put Options Held

2.58M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.48B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Exact Sciences Corp Transaction History